파르네센 시장 예측(2026-2032년)

The Farnesene Market is projected to grow by USD 314.53 million at a CAGR of 6.50% by 2032.

Farnesene Executive Summary: Renewable Platform Molecule for Bio-Based Chemicals and Performance Applications

Farnesene is a bio-based sesquiterpene increasingly positioned at the intersection of renewable chemicals, advanced fuels, cosmetics ingredients, polymers, lubricants, flavors and fragrances, and pharmaceutical intermediates. Produced naturally by plants and commercially through engineered microbial fermentation of sugar-derived feedstocks, farnesene offers a platform molecule pathway to ingredients such as squalane, specialty elastomers, surfactant precursors, emollients, diesel-range hydrocarbons, and high-performance lubricant components. Its relevance is strengthening as downstream industries seek lower-carbon alternatives to petroleum-derived molecules while maintaining performance, purity, and supply reliability. The farnesene landscape is shaped by fermentation efficiency, feedstock availability, life-cycle emissions, regulatory acceptance, and end-use qualification requirements across highly technical industries. Demand signals are particularly linked to clean-label personal care formulations, renewable hydrocarbon chemistry, specialty materials innovation, and decarbonization strategies in transport and industrial applications. As sustainability standards, traceability expectations, and bioeconomy policies become more rigorous, farnesene is gaining attention as a scalable renewable intermediate with the potential to support circular and low-carbon value chains without compromising functional performance.

Transformative Shifts Reshaping the Farnesene Value Chain

The farnesene landscape is undergoing transformative shifts driven by the convergence of synthetic biology, industrial biotechnology, sustainability regulation, and performance-led materials innovation. Traditional dependence on petrochemical building blocks is being reassessed as formulators and manufacturers prioritize renewable carbon, lower environmental impact, and supply chain diversification. Advances in strain engineering, fermentation process control, downstream purification, and catalytic upgrading are improving the commercial viability of farnesene-derived ingredients and intermediates. In personal care, the shift from animal-derived and petroleum-derived emollients toward plant-based and fermentation-derived alternatives supports the use of farnesene-derived squalane and related compounds. In mobility and industrial sectors, renewable hydrocarbons derived from farnesene are being evaluated for compatibility with existing infrastructure and high-performance specifications. Meanwhile, procurement teams are placing greater emphasis on certified feedstocks, carbon accounting, and transparent sourcing, influencing supplier qualification and offtake decisions. The competitive basis is moving beyond simple renewability toward a combination of technical performance, regulatory readiness, scalable manufacturing, and demonstrable life-cycle benefits.

Cumulative Impact of Artificial Intelligence on Farnesene Innovation and Manufacturing

Artificial intelligence is increasingly influencing the farnesene ecosystem by accelerating discovery, optimization, and operational decision-making across the bio-based chemicals value chain. In upstream research, AI-enabled metabolic modeling helps identify enzyme targets, pathway bottlenecks, and strain engineering strategies that can improve microbial conversion of sugars into farnesene. Machine learning tools support fermentation optimization by analyzing variables such as pH, temperature, dissolved oxygen, nutrient concentration, substrate utilization, and byproduct formation, enabling faster process stabilization and improved reproducibility. In downstream processing, AI can enhance separation efficiency, impurity detection, energy optimization, and predictive maintenance of fermentation and purification assets. For end-use development, computational chemistry and AI-assisted formulation tools can predict how farnesene derivatives behave in cosmetics, elastomers, fuels, lubricants, and specialty chemical systems. The cumulative impact is a shorter development cycle, better process reliability, stronger quality control, and more efficient regulatory documentation. However, successful AI adoption depends on high-quality experimental datasets, domain-specific validation, cybersecurity safeguards, and integration between laboratory, pilot, and production environments.

Key Regional Insights for Farnesene Across Asia-Pacific, Europe, North America, Latin America, Africa, and the Middle East

Asia-Pacific is emerging as a strategic region for farnesene due to its extensive manufacturing base, growing personal care consumption, expanding biotechnology capabilities, and government support for bio-based industrial development in economies such as China, India, Japan, South Korea, and Australia. The region's role in sugar, starch, and biomass supply chains also supports interest in fermentation-based chemicals, although feedstock competition, land-use considerations, and quality consistency remain important factors. Europe is shaped by stringent sustainability regulation, circular economy policies, renewable content expectations, and high demand for bio-based ingredients in cosmetics, specialty chemicals, and advanced materials; regulatory frameworks for chemicals management, product safety, cosmetics compliance, and environmental claims strongly influence product adoption. North America benefits from mature industrial biotechnology infrastructure, strong research ecosystems, and policy momentum around renewable fuels, bio-based chemicals, and domestic supply chain resilience, making it a critical region for process development, qualification, and high-value applications. Latin America offers feedstock advantages through sugarcane and other agricultural resources, with Brazil and Mexico playing important roles in bioeconomy discussions, renewable carbon strategies, and potential fermentation input availability. Africa presents longer-term opportunities linked to agricultural feedstocks, emerging industrial biotechnology, and regional value addition, while infrastructure, financing, and technology transfer remain decisive for scalable adoption. The Middle East is evaluating bio-based and low-carbon chemical diversification as part of broader industrial transformation, with potential relevance in specialty chemicals, lubricants, and downstream petrochemical integration.

Key Group Insights Highlighting Farnesene Adoption Across NATO, G7, BRICS, the EU, ASEAN, and GCC Economies

NATO economies are relevant where energy security, supply chain resilience, and domestic production of critical industrial inputs intersect with renewable chemical strategies, including potential defense-adjacent needs for specialty fuels, lubricants, and resilient materials supply chains. G7 countries remain important for advanced R&D, high-purity applications, product certification, and policy frameworks supporting bioeconomy development, particularly in cosmetics, fuels, performance materials, and specialty chemicals. BRICS economies collectively influence the farnesene landscape through their scale in agriculture, industrial manufacturing, energy transition initiatives, and biotechnology investment, although regulatory alignment and infrastructure maturity vary across members. The European Union is one of the most influential groupings for farnesene adoption because of its advanced sustainability regulation, chemicals safety requirements, renewable carbon agenda, and consumer preference for bio-based personal care and household products. ASEAN is gaining relevance in the farnesene value chain as a manufacturing and consumer hub with rising demand for cosmetics, personal care, and sustainable ingredients, while regional agricultural resources may support bio-based feedstock strategies when aligned with responsible sourcing standards. The GCC's interest is linked to economic diversification, specialty chemical development, and low-carbon industrial initiatives, creating potential pathways for farnesene-derived lubricants, polymers, and renewable intermediates to complement existing chemical ecosystems.

Key Country Insights Covering Farnesene Opportunities in Major Industrial and Bioeconomy Markets

China combines large-scale chemical manufacturing, biotechnology investment, and expanding consumer demand, making it central to both production and application development for farnesene-derived ingredients and renewable intermediates. The United States is a leading environment for farnesene development due to its established industrial biotechnology sector, renewable fuel policy experience, advanced fermentation expertise, and strong demand for sustainable specialty chemicals and personal care ingredients. Japan and South Korea contribute advanced materials expertise, high-purity manufacturing standards, and innovation in cosmetics, polymers, and mobility applications, while India's growing personal care, pharmaceutical, and specialty chemical sectors, combined with sugar-based feedstock potential, support interest in fermentation-derived intermediates. In Europe, Germany, the United Kingdom, France, Italy, and Spain demonstrate demand drivers tied to sustainable cosmetics, specialty chemicals, automotive materials, and regulatory preference for safer and renewable alternatives; Germany's chemical engineering capabilities and France's cosmetics and fragrance ecosystem are especially aligned with high-value farnesene derivatives. Australia is relevant through its bioeconomy research, agricultural resources, and sustainability-driven industrial initiatives, especially where renewable feedstocks and regional supply resilience are prioritized. Canada supports opportunities through clean technology initiatives, biomass availability, and interest in low-carbon industrial supply chains, while Russia's relevance is shaped by its chemical and energy industries, though geopolitical and trade constraints affect international collaboration and supply chain access. Brazil is particularly important because of its sugarcane-based bioeconomy, renewable fuel experience, and potential to support fermentation-derived molecules through agricultural productivity and bioindustrial know-how, while Mexico's manufacturing integration and agricultural resources create relevance for regional feedstock and downstream formulation strategies.

Actionable Recommendations for Farnesene Industry Leaders

Industry leaders should prioritize integrated strategies that connect feedstock security, fermentation performance, downstream application validation, and sustainability proof. Producers can strengthen competitiveness by investing in strain improvement, robust process analytics, energy-efficient purification, and catalytic conversion capabilities for farnesene derivatives. Downstream users should evaluate farnesene not only as a renewable substitute but as a performance-enabling molecule with application-specific advantages in emolliency, oxidative stability, hydrocarbon compatibility, viscosity control, or polymer functionality. Procurement and sustainability teams should establish traceability protocols, verify renewable content, assess life-cycle impacts, and align supply contracts with credible certification schemes. R&D leaders should develop co-innovation partnerships with formulators, material scientists, and regulatory experts to accelerate qualification in cosmetics, lubricants, fuels, elastomers, and specialty ingredients. Manufacturers should diversify feedstock sources and assess exposure to sugar price volatility, water use, land-use concerns, and regional logistics constraints. Decision-makers should also adopt AI-enabled process optimization and digital quality systems while ensuring data integrity, regulatory compliance, and scalable technology transfer from pilot to commercial operations.

Research Methodology for Farnesene Industry Analysis

This executive summary is developed using a structured secondary research approach focused on verified public-domain and industry-recognized sources relevant to farnesene, industrial biotechnology, renewable chemicals, bio-based ingredients, and sustainability regulation. The methodology emphasizes triangulation across scientific literature, patent landscapes, regulatory frameworks, government bioeconomy policies, standards bodies, trade publications, and technical documentation related to fermentation, renewable hydrocarbons, cosmetics ingredients, specialty materials, and chemical safety. Regional and country insights are interpreted through documented industrial capabilities, feedstock availability, policy direction, end-use demand indicators, and sustainability requirements. The analysis excludes market sizing, market share, and forecasting and instead focuses on qualitative evidence, technology readiness considerations, regulatory drivers, supply chain dynamics, and application relevance. Data integrity is supported by cross-checking claims across multiple credible sources and avoiding unverified promotional statements. The research framework also considers practical adoption factors such as feedstock traceability, life-cycle assessment, product qualification cycles, manufacturing scalability, and compliance with regional product and chemical regulations.

Conclusion: Farnesene's Role in the Renewable Chemicals Transition

Farnesene is evolving from a specialized bio-based molecule into a versatile renewable platform for high-value applications across cosmetics, specialty chemicals, fuels, lubricants, polymers, and advanced materials. Its strategic appeal lies in the combination of renewable carbon sourcing, functional performance, and compatibility with broader decarbonization and bioeconomy objectives. Adoption is being shaped by advances in synthetic biology, fermentation optimization, AI-enabled process intelligence, and growing demand for traceable sustainable ingredients. Regional momentum differs by feedstock base, industrial biotechnology maturity, regulatory environment, and end-use industry structure, with Asia-Pacific, Europe, North America, and Latin America playing particularly important roles in the global development pathway. To capture long-term value, industry participants must move beyond renewability claims and demonstrate measurable performance, responsible sourcing, regulatory compliance, and life-cycle benefits. Organizations that integrate biotechnology innovation with application expertise, digital manufacturing, and credible sustainability validation will be best positioned to advance farnesene as a critical building block in the transition toward resilient, low-carbon chemical value chains.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Farnesene Market, by Source

• 7.1. Introduction
• 7.2. Bio-Based
  • 7.2.1. Sugarcane
  • 7.2.2. Corn
• 7.3. Synthetic

8. Farnesene Market, by Production Process

• 8.1. Introduction
• 8.2. Biotechnological Fermentation
  • 8.2.1. Yeast Fermentation
  • 8.2.2. Bacterial Fermentation
  • 8.2.3. Genetically Engineered Microorganisms
• 8.3. Chemical Synthesis
• 8.4. Hybrid Processes

9. Farnesene Market, by Purity Level

• 9.1. Introduction
• 9.2. Below 85 Percent
• 9.3. 85 To 95 Percent
• 9.4. Above 95 Percent
• 9.5. Custom Grades

10. Farnesene Market, by Form

• 10.1. Introduction
• 10.2. Liquid
• 10.3. Encapsulated
• 10.4. Blended Formulations

11. Farnesene Market, by Application

• 11.1. Introduction
• 11.2. Fragrances & Flavors
  • 11.2.1. Fine Fragrances
  • 11.2.2. Personal Care & Cosmetics
  • 11.2.3. Food & Beverages
    • 11.2.3.1. Beverages
    • 11.2.3.2. Confectionery & Bakery
    • 11.2.3.3. Savory & Snacks
• 11.3. Fuels & Lubricants
  • 11.3.1. Biojet Fuel
  • 11.3.2. Diesel & Gasoline Blending
  • 11.3.3. Lubricant Additives
• 11.4. Polymers & Resins
  • 11.4.1. Thermoplastic Elastomers
  • 11.4.2. Polyamides
  • 11.4.3. Polyurethanes
• 11.5. Adhesives & Sealants
• 11.6. Agrochemicals
  • 11.6.1. Insect Pheromones
  • 11.6.2. Crop Protection Formulations
• 11.7. Pharmaceuticals & Nutraceuticals

12. Farnesene Market, by Region

• 12.1. Asia-Pacific
• 12.2. Europe
• 12.3. North America
• 12.4. Latin America
• 12.5. Africa
• 12.6. Middle East

13. Farnesene Market, by Group

• 13.1. NATO
• 13.2. G7
• 13.3. BRICS
• 13.4. European Union
• 13.5. ASEAN
• 13.6. GCC

14. Farnesene Market, by Country

• 14.1. China
• 14.2. United States
• 14.3. Japan
• 14.4. India
• 14.5. Germany
• 14.6. United Kingdom
• 14.7. Australia
• 14.8. France
• 14.9. South Korea
• 14.10. Italy
• 14.11. Canada
• 14.12. Russia
• 14.13. Brazil
• 14.14. Mexico
• 14.15. Spain

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. FPNV Positioning Matrix, 2025
• 15.3. Market Concentration Analysis, 2025
  • 15.3.1. Concentration Ratio (CR)
  • 15.3.2. Herfindahl Hirschman Index (HHI)
• 15.4. Recent Developments & Impact Analysis, 2025
• 15.5. Product Portfolio Analysis, 2025
• 15.6. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Abstrax Tech, Inc.
• 16.2. Alfa Chemistry
• 16.3. Amyris, Inc.
• 16.4. Arzeda
• 16.5. Axxence Aromatic GmbH
• 16.6. BASF SE
• 16.7. Bedoukian Research Inc.
• 16.8. Biomol GmbH
• 16.9. BOC Sciences
• 16.10. CATO Research Chemical Inc.
• 16.11. Cayman Chemical
• 16.12. Genomatica, Inc.
• 16.13. Glentham Life Sciences Limited
• 16.14. Global Bioenergies
• 16.15. Jinan Future Chemical Industry Co.,Ltd.
• 16.16. Kuraray Co., Ltd.
• 16.17. LanzaTech
• 16.18. Merck KGaA
• 16.19. Penta Manufacturing Company
• 16.20. Precigen, Inc.
• 16.21. Santa Cruz Biotechnology, Inc.
• 16.22. SIELC Technologies
• 16.23. SimSon Pharma Limited
• 16.24. Tokyo Chemical Industry Co., Ltd
• 16.25. Toronto Research Chemicals Inc.
• 16.26. Triveni Chemicals
• 16.27. United States Biological Life Science
• 16.28. Wuhan Hesheng Technology Co., Ltd